Cholesterol-lowering drug for recent stroke from narrowed brain artery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a cholesterol-lowering medicine (called a PCSK9 inhibitor) can help people who recently had a stroke caused by a narrowed artery in the brain. The goal is to see if it reduces the risk of another stroke or helps recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 80 years old.
- You had a stroke from a blocked artery in the brain within the last 72 hours (3 days).
- Your stroke was moderately severe, as measured by a standard scale.
- Imaging shows the narrowed artery is due to plaque buildup (atherosclerosis), not other causes.
- You have not had a stent placed in that artery and aren't planning one in the next 3 months.
- You are not currently taking certain cholesterol-lowering injections (PCSK9 inhibitors) or have not taken them recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This trial tests whether tirzepatide, a medication typically used for diabetes, can improve recovery after a stroke caused by a blocked artery in the brain that was treated with a clot-removal procedure. It may help reduce further damage and support better outcomes.
This trial tests whether adding an intensive cholesterol-lowering drug (called a PCSK9 inhibitor) to standard care can reduce the risk of another stroke or heart attack in people who recently had a stroke from narrowed brain or neck arteries. It is a high-dose approach designed to rapidly lower cholesterol and may offer extra protection for those with high Lp(a).
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
This study tests whether starting a cholesterol-lowering injection (a PCSK9 inhibitor) early after a heart attack can slow or shrink the buildup of plaque in other heart arteries that are not the one that was stented. If you have two other arteries with mild blockages, this treatment might help prevent future heart problems.
This clinical trial tests whether a new cholesterol-lowering medicine can reduce the risk of another stroke in people who recently had a stroke or mini-stroke caused by a narrowed artery in the brain. The study compares the new medicine to a placebo (a dummy pill) to see if it helps prevent future problems.
Hear when a new Atherosclerotic Plaque trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.